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In a 7-year population-based study in Malawi, we
showed that Beijing genotype tuberculosis (TB) increased
as a proportion of TB cases. All the Beijing genotype strains
were fully drug sensitive. Contact histories, TB type, and
case-fatality rates were similar for Beijing and non-Beijing
genotype TB.
The Beijing genotype family of Mycobacterium tuber-culosis may be spreading worldwide. The genotype
may be particularly virulent and have a predilection for
developing drug resistance; the multidrug-resistant W
strain is a member of this family (1). Few studies have
examined trends in the prevalence of Beijing genotype
strains over time, and little is known about their distribu-
tion or characteristics in Africa (2), although drug-resistant
Beijing genotype strains have been identified in Cape
Town and Nairobi (3,4). We describe Beijing genotype
tuberculosis (TB) in a population-based, 7-year study in
Malawi.
The Study
As part of the Karonga Prevention Study, a longstand-
ing epidemiologic study of TB and HIV in a rural area of
northern Malawi (5,6), persons suspected of having TB in
Karonga District are identified at the hospital and periph-
eral clinics. Sputum is taken for smear and culture.
Cultures are also performed on lymph node aspirates and
other samples as appropriate. Treatment follows Malawi
National TB Control Programme guidelines, and drug
resistance has remained low, with initial isoniazid resist-
ance ≈6% during this study (7,8). 
Positive cultures from all patients in whom TB has been
diagnosed since late 1995 have been DNA fingerprinted
(9). Fingerprinting used IS6110 restriction fragment length
polymorphism (RFLP) following standard guidelines (10),
and RFLP patterns were compared by using computer-
assisted (Gelcompar 4.1, Applied Maths, Kortrijk,
Belgium) visual comparison. Beijing genotype strains
were identified by comparing each RFLP pattern to 19 ref-
erence RFLP patterns (https://hypocrates.rivm.nl/bnwww/
index.html) with 1% position tolerance. Taking strains
with patterns with >80% similarity to any of the reference
patterns as Beijing genotype, and spoligotyping strains
showing 75%–80% similarity, this method has been shown
to identify Beijing genotype strains with a sensitivity of
96% to 100% and specificity of 98% to 100%, using
spoligotyping as the gold standard (11). In the present
study, we spoligotyped all strains with RFLP patterns with
>70% similarity to the reference patterns in order to max-
imize the sensitivity and specificity for identifying Beijing
genotype strains. 
From late 1995 to early 2003, a total of 1,194 speci-
mens were fingerprinted from 1,044 persons (84% of
patients in whom culture-positive TB was diagnosed in
this period). After excluding likely laboratory errors (9)
(25 isolates) and multiple isolates per person, we found
406 different RFLP patterns in samples from 1,029
patients. Overall, 757 patients (73.6%) were clustered, i.e.,
they had an isolate with an RFLP pattern that was identical
to that of at least 1 other patient in the study. 
Thirteen different RFLP patterns from isolates from 45
patients matched the Beijing genotype reference patterns
by >75%. At least 1 isolate from each of the 13 strains was
spoligotyped: 12 patterns were confirmed as Beijing geno-
type. The RFLP pattern from the strain with the non-
Beijing genotype on spoligotyping, present in only 1
patient, matched the RFLP pattern of a reference strain by
81% but showed a <73% match with the other reference
RFLP patterns and a <71% match with the other 12 Beijing
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Figure 1. Restriction fragment length polymorphism patterns of 12
Beijing strains from Karonga District, Malawi. All strains were  79%
related to at least 1 of the other Beijing strains found in the district.
Strain MT14323 is a reference strain.
genotype RFLP patterns from Malawi. In the whole
dataset, only 3 other strains had RFLP patterns that
matched the reference set by >70% (and <75%): spoligo-
typing confirmed that these strains were not Beijing geno-
type. The RFLP patterns of the 12 Beijing genotype strains
from Karonga District are shown in Figure 1. 
Overall 44 (4.3%) of 1,029 patients had Beijing geno-
type TB (Table). Beijing genotype strains were found in
persons from all areas of the district, and they were no more
common in those who had lived outside Malawi. Of the 8
people with Beijing genotype TB who had been born out-
side Malawi or lived outside Malawi in the last 5 years, 4
were from Tanzania and 4 from Zambia. Among TB
patients, no association was seen between Beijing genotype
and HIV status. Beijing genotype strains were more com-
mon in women than in men, and this difference persisted
after adjusting for age and year of diagnosis (adjusted odds
ratio [OR] 2.9, 95% confidence interval [CI] 1.4–6.0). 
The proportion of TB due to Beijing genotype strains
increased over time (Figure 2, OR 1.2, 95% CI 1.0–1.4 for
each year of study, p = 0.03) and was slightly lower in older
persons (p = 0.2, test for trend). Of the 12 different Beijing
genotype RFLP patterns, 5 were shared by >2 patients (i.e.,
were clustered), and the remaining 7 were unique in the
dataset. The proportion of patients who were clustered was
slightly higher in those with Beijing genotype strains than
among those with other strains (84% vs. 71%, p = 0.07,
after excluding those with <5 bands on the RFLP pattern).
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Both the time trend and the association with age sug-
gest an increase in Beijing genotype TB, and the associa-
tion with clustering might suggest higher transmissibility.
These results were influenced by the appearance of strain
KPS332 from October 2001 onwards, affecting 10
patients. This strain was 83% similar to strain KPS96 and
more distantly related to the other strains, so this strain was
probably newly introduced into the district. However, an
increase over time was also apparent in the data before
2001 (OR 1.3, 95% CI 0.98–1.8, for each year of study, p
= 0.07), and the trend with age was stronger for this earli-
er period (p = 0.07). 
Since 1997, patients have been asked about contacts
they had had with persons in whom TB had been diag-
nosed. Further potential source contacts were identified
from the project database by identifying relatives and those
sharing a household. The diagnosis of TB in these named
contacts was checked with the project database (9). Two
patients with strain KPS332 were relatives. 
Overall, approximately half of those with Beijing geno-
type TB and of those with other strains had identified con-
tact with previous TB patients (Table). Among the 219
persons who were named as potential source contacts and
had RFLP results, 10 (4.6%) had Beijing genotype strains,
similar to the proportion in the whole population. Some
contacts were named more than once. The proportion of
case-patients who had identical RFLP patterns to these
source contacts, confirming transmission, was similar for
contacts with Beijing genotype strains (3 [20%] of 15 con-
tact pairs) and those with other strains (61 [21%] of 289,
p = 0.9). Since the proportion of contacts with the Beijing
genotype is similar to the proportion with Beijing genotype
in the whole population, and since the proportion of trans-
missions that were confirmed by RFLP was similar for
those with Beijing genotype and those with other geno-
types, this analysis provides no evidence of increased
transmissibility of Beijing genotype strains. In addition,
those with Beijing genotype were no more likely to be
smear-positive than were those with other genotypes
(Table). 
Drug resistance was tested to isoniazid and rifampicin
(rifampin). If resistance was found, sensitivity to other
drugs was tested as well. None of the Beijing genotype
strains had any drug resistance, compared to 6.1% of other
strains (p = 0.1). 
Outcome data were available for 92% of patients. After
excluding 154 patients (3 with Beijing genotype) who
were lost to follow-up or transferred, we found that the
proportion who died during treatment was similar for those
with Beijing genotype strains as for the other patients
(Table). These results were little altered by adjusting for
year of diagnosis, age, sex, or HIV status. 
Conclusions
Beijing genotype strains of M. tuberculosis are present
in northern Malawi. The variety of RFLP patterns suggests
several different introductions of Beijing genotype strains
into the district. The origin of these strains is unknown, but
they may have come directly from Asia, where they are
common (12): Chinese people have worked in the district,
for example, as agricultural advisors, in the last 20 years.
The proportion of TB cases caused by Beijing genotype
strains increased over the period of the study. This increase
was exacerbated by 10 cases with a single RFLP pattern
occurring within the last 12 months, which suggests an
outbreak, although epidemiologic links were only estab-
lished for 2 cases. No association with drug resistance was
seen, and no evidence of increased severity or transmissi-
bility of TB was seen in those with Beijing genotype.
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Figure 2. Beijing genotype tuberculosis (TB) in Karonga District,
Malawi, over time. The solid lines show the number of persons
with each Beijing genotype restriction fragment length polymor-
phism (RFLP) pattern, and the dotted line shows the proportion of
culture-positive TB cases that are due to the Beijing genotype.
Because strains KPS97 (14 patients) and KPS385 (2 patients) dif-
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